Next Article in Journal / Special Issue
The Influence of Body Composition on the Systemic Exposure of Paclitaxel in Esophageal Cancer Patients
Previous Article in Journal
Drug Repurposing: Dipeptidyl Peptidase IV (DPP4) Inhibitors as Potential Agents to Treat SARS-CoV-2 (2019-nCoV) Infection
Previous Article in Special Issue
Association of 5-FU Therapeutic Drug Monitoring to DPD Phenotype Assessment May Reduce 5-FU Under-Exposure
 
 
Case Report

Article Versions Notes

Pharmaceuticals 2021, 14(1), 46; https://doi.org/10.3390/ph14010046
Action Date Notes Link
article xml file uploaded 9 January 2021 08:48 CET Original file -
article xml uploaded. 9 January 2021 08:48 CET Update https://www.mdpi.com/1424-8247/14/1/46/xml
article pdf uploaded. 9 January 2021 08:48 CET Version of Record https://www.mdpi.com/1424-8247/14/1/46/pdf
article html file updated 9 January 2021 08:50 CET Original file -
article html file updated 23 July 2022 12:54 CEST Update https://www.mdpi.com/1424-8247/14/1/46/html
Back to TopTop